ZSCAN4B inhibitors represent a class of chemical compounds that modulate the activity of the ZSCAN4B protein, which belongs to the zinc finger and SCAN domain-containing (ZSCAN) family. The ZSCAN family of proteins plays a significant role in the regulation of various cellular processes, including gene expression, chromatin remodeling, and cellular senescence. ZSCAN4B, in particular, is involved in the maintenance of genomic stability and has been found to contribute to the regulation of telomere elongation through noncanonical pathways. Inhibitors targeting ZSCAN4B typically act by binding to the active sites or allosteric regions of the protein, thereby interfering with its ability to modulate transcriptional activity and chromosomal dynamics. This interference can affect chromatin accessibility and gene regulatory networks, which are critical in cellular differentiation and proliferation.
Chemically, ZSCAN4B inhibitors may feature diverse molecular architectures, including heterocyclic scaffolds or small peptides, designed to interact with the zinc finger domains that are critical for DNA binding. The design and optimization of these inhibitors rely on detailed structural biology studies, such as X-ray crystallography or nuclear magnetic resonance (NMR) spectroscopy, to elucidate the protein's structure-function relationship. In addition, computational modeling and molecular docking techniques are employed to predict and refine inhibitor binding affinities. These inhibitors are useful tools for understanding the fundamental role of ZSCAN4B in the context of chromatin organization and gene expression regulation. Furthermore, they offer insights into the dynamics of telomere-associated proteins, contributing to broader research in molecular biology and cellular homeostasis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $260.00 $925.00 | 5 | |
C646, a histone acetyltransferase (HAT) inhibitor, may inhibit ZNF644 expression by modulating histone acetylation, which affects chromatin structure and subsequent gene transcription. | ||||||
Verteporfin | 129497-78-5 | sc-475698 sc-475698A | 10 mg 100 mg | $347.00 $2710.00 | 5 | |
Verteporfin may impact ZNF644 expression by interfering with the YAP-TEAD interaction, leading to downstream effects on gene transcription and cellular processes. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, may affect ZNF644 expression by modulating the acetylation status of histones, thereby impacting gene transcription. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
JQ1, a bromodomain and extraterminal (BET) protein inhibitor, may inhibit ZNF644 expression by interfering with the binding of BET proteins to acetylated histones, affecting gene transcription. | ||||||
Scriptaid | 287383-59-9 | sc-202807 sc-202807A | 1 mg 5 mg | $63.00 $179.00 | 11 | |
Scriptaid, a histone deacetylase inhibitor, may inhibit ZNF644 expression by modulating histone acetylation, which affects chromatin structure and subsequent gene transcription. | ||||||
JIB 04 | 199596-05-9 | sc-397040 | 20 mg | $177.00 | ||
JIB-04, a Jumonji histone demethylase inhibitor, may impact ZNF644 expression by modulating the methylation status of histones, thereby affecting gene transcription. | ||||||
Tubastatin A | 1252003-15-8 | sc-507298 | 10 mg | $112.00 | ||
Tubastatin A, a histone deacetylase 6 (HDAC6) inhibitor, may affect ZNF644 expression by modulating the acetylation status of histones, thereby impacting gene transcription. | ||||||
PFI-1 | 1403764-72-6 | sc-478504 | 5 mg | $96.00 | ||
PFI-1, a protein interaction inhibitor, may inhibit ZNF644 expression by interfering with the binding of specific protein partners, thereby impacting gene transcription. | ||||||
Histone Lysine Methyltransferase Inhibitor Inhibitor | 935693-62-2 free base | sc-202651 | 5 mg | $148.00 | 4 | |
CPI-203, a histone methyltransferase inhibitor, may impact ZNF644 expression by modulating the methylation status of histones, thereby affecting gene transcription. | ||||||
GSK-J4 | 1373423-53-0 | sc-507551 | 100 mg | $1275.00 | ||
GSK-J4, a histone demethylase inhibitor, may inhibit ZNF644 expression by modulating the demethylation status of histones, thereby affecting gene transcription. | ||||||